- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04904731
Effects of Body Position on Diaphragmatic Activity in Patients Requiring Noninvasive Ventilation for Acute Respiratory Failure COVID-19 Related (DiaCOVIDProne)
Study Overview
Status
Intervention / Treatment
Detailed Description
Primary aim is to asses the effects of body position on diaphragmatic thickening fraction (primary aim) and lung aeration and vital sign (secondary aims) in patents assisted via noninvasive ventilation (NIV) for hypoxemic acute respiratory failure (hARF) associated to COVID-19. All adult patients, admitted for hARF due to COVID-19 and requiring NIV were enrolled.
Diaphragmatic thickening fraction, lung aeration assessed through ultrasound, comfort, and grade of sedation-agitation as well as vital signs, i.e., peripheral oxygen saturation, blood pressure, and breathing pattern were monitored during noninvasive ventilation in supine and after 1 hour following the switch to prone position.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Umbria
-
Perugia, Umbria, Italy, 06156
- Gianmaria Cammarota
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- COVID-19 infection,
- Age > 18 years,
- NIV application,
- ICU admission
Exclusion Criteria:
- Pregnancy,
- All the conditions contraindicating prone position and NIV
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diaphragmatic thickening fraction
Time Frame: At baseline, in supine position
|
The fraction of diaphragmatic thickness variations during respiratory cycle
|
At baseline, in supine position
|
|
Diaphragmatic thickening fraction
Time Frame: After 1 hour following prone position application
|
The fraction of diaphragmatic thickness variations during respiratory cycle
|
After 1 hour following prone position application
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lung aeration
Time Frame: At baseline, in supine position
|
Lung aeration assessed through sonography
|
At baseline, in supine position
|
|
Peripheral oxygen saturation
Time Frame: At baseline, in supine position
|
Reflects the grade of peripheral oxygenation
|
At baseline, in supine position
|
|
Lung aeration
Time Frame: after 1 hour following prone position application
|
Lung aeration assessed through sonography
|
after 1 hour following prone position application
|
|
Peripheral oxygen saturation
Time Frame: after 1 hour following prone position application
|
Reflects the grade of peripheral oxygenation
|
after 1 hour following prone position application
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3658/20
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.